Skip to main content
TipRanks
Go Ultimate75% OFF

Karyopharm Therapeutics (25K0) Q2 2022 Earnings Report

1 Followers

DE:25K0 Q2 2022 EPS Results

Actual EPS
-EUR 8.34
Consensus EPS
-EUR 8.52
Beat/Miss
Beat by +EUR 0.18
One Year Ago EPS
-EUR 9.55

DE:25K0 Q2 2022 Revenue Results

Actual Revenue
EUR 35.58M
Expected Revenue
EUR 32.25M
Beat/Miss
Beat by +EUR 3.33M
YoY Revenue Growth
+75.56%

Earnings Announcement Details

Quarter
Q2 2022
Date
08/04/2022
Time
Before Open
Conference Call
Thursday, August 4, 2022
DE:25K0 Upcoming Earnings

Karyopharm Therapeutics's next earnings date is estimated for February 10, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:25K0 Earnings History

DE:25K0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 10, 20272026 (Q4)―--5.12――
Oct 29, 20262026 (Q3)-0.30--3.43―
Aug 13, 20262026 (Q2)-1.23-2.08-3.8746.30% (+1.79)
May 14, 20262026 (Q1)-1.27-1.11-2.4855.23% (+1.37)
Feb 12, 20262025 (Q4)-1.79-5.12-3.23-58.61% (-1.89)
Nov 03, 20252025 (Q3)-3.11-3.43-3.52.05% (+0.07)
Aug 11, 20252025 (Q2)-3.66-3.87-2.69-44.00% (-1.18)
May 12, 20252025 (Q1)-3.96-2.48-4.342.29% (+1.82)
Feb 19, 20252024 (Q4)-3.52-3.23-4.8433.33% (+1.61)
Nov 05, 20242024 (Q3)-3.54-3.50-4.0413.33% (+0.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed